674
Views
3
CrossRef citations to date
0
Altmetric
Hemoglobinopathy

The possible role of reticulocytes in sickle cell disease associated thromboembolism

Pages 68-70 | Published online: 18 Jul 2013

References

  • Ataga KI, Orringer EP. Hypercoagulability in sickle cell disease: acurious paradox. Am J Med 2003; 115: 721–728.
  • Barker JE, Wandersee NJ. Thrombosis in heritable hemolytic disorders. Curr Opin Hematol 1999; 6: 71–75.
  • Francis RB Jr. Platelets, coagulation, and fibrinolysis in sickle celldisease: their possible role in the vascular occlusion. Blood Coagul Fibrinolysis 1991; 2: 341–353.
  • Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia. Blood 2002; 99: 36–43.
  • Kuypers FA, Lewis RA, Hua M et al. Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V. Blood 1996, 87: 1179–1187.
  • Middelkoop E, Lubin BH, Bevers EM et al. Studies on sickled erythrocytes provide evidence that the asymmetric distribution of phosphatidylserine in the red cell membrane is maintained by both ATP-dependent translocation and interaction with membrane skeletal proteins. Brioche Biophys Acta 1988; 937: 281–288.
  • Tait JF, Gibson D. Measurement of membrane phospholipid asymmetry in normal and sickle cell erythrocytes by means of annexin V binding. J Lab Clin Med 1994; 123: 741–748.
  • Atichartakarn V, Angchaisuksiri P, Aryurachai K et al. Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E/ beta-thalassaemic patients. Br J Haematol 2002; 118: 893–898.
  • Hall C, Richards S, Hillmen P. Primary prophylaxis with warfarinprevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH). Blood 2003; 102: 3587–3591.
  • Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 2005; 293: 1653–1662.
  • Bunn HF. Pathogenesis and treatment of sickle cell disease. N EnglJ Med 1997; 337: 762–769.
  • Wang WC, Morales KH, Scher CD et al. Effect of long-term transfusion on growth in children with sickle cell anemia: results of the STOP trial. J Pediatr 2005; 147: 244–247.
  • Adams RJ, McKie VC, Hsu L et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998; 339: 5–11.
  • Gulbis B, Haberman D, Dufour D et al. Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience. Blood 2005; 105: 2685–2690.
  • Ware RE, Zimmerman SA, Sylvestre PB et al. Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebot-omy. J Pediatr 2004; 145: 346–352.
  • Ferster A, Tahriri P, Vermylen C et al. Five years of experience with hydroxyurea in children and young adults with sickle cell disease. Blood 2001; 97: 3628–3632.
  • Yang YM, Pace B, Kitchens D, Ballas SK, Shah A, Baliga BS. BFU-E colony growth in response to hydroxyurea: correlation between in vitro and in vivo fetal hemoglobin induction. Am J Hematol 1997; 56: 252–258.
  • Steinberg MH, Lu ZH, Barton FB, Terrin ML, Charache S, Dover GJ. Multicenter study of hydroxyurea. Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Blood 1997; 89: 1078–1088.
  • Pullarkat V, Ngo M, Iqbal S, Espina B, Liebman HA. Detection of lupus anticoagulant identifies patients with autoimmune haemoly-tic anaemia at increased risk for venous thromboembolism. Br J Haematol 2002; 118: 1166–1169.
  • Hendrick AM. Autoimmune haemolytic anaemia--a high-risk disorder for thromboembolism? Hematology 2003; 8: 53–56.
  • Koury MJ, Koury ST, Kopsombut P, Bondurant MC. In vitro maturation of nascent reticulocytes to erythrocytes. Blood 2005; 105: 2168–2174.
  • Come SE, Shohet SB, Robinson SH. Surface remodeling of reticulocytes produced in response to erythroid stress. Nat New Biol 1972; 236: 157–158.
  • Patel VP, Ciechanover A, Platt O, Lodish HF. Mammalian reticulocytes lose adhesion to fibronectin during maturation to erythrocytes. Proc Nail Acad Sci USA 1985; 82: 440–444.
  • Chasis JA, Prenant M, Leung A, Mohandas N. Membrane assembly and remodeling during reticulocyte maturation. Blood 1989; 74: 1112–1120.
  • Johnstone RM, Mathew A, Mason AB, Teng K. Exosome formation during maturation of mammalian and avian reticulo-cytes: evidence that exosome release is a major route for externalization of obsolete membrane proteins. J Cell Physiol 1991; 147: 27–36.
  • Rabesandratana H, Toutant JP, Reggio H, Vidal M. Decay-accelerating factor (CD55) and membraneinhibitor of reactive lysis (CD59) are released within exosomes during in vitro maturation of reticulocytes. Blood 1998; 91: 2573–2580.
  • Rieu S, Geminard C, Rabesandratana H, Sainte-Marie J, Vidal M. Exosomes released during reticulocyte maturation bind to fibro-nectin via integrin alpha 4 beta 1 . Eur J Biochem 2000; 267: 583–590.
  • Heynen MJ, Tricot G, Verwilghen RL. Autophagy of mitochon-dria in rat bone marrow erythroid cells: relation to nuclear extrusion. Cell Tissue Res 1985; 239: 235–239.
  • Gasko O, Danon D. Deterioration and disappearance of mito-chondria during reticulocyte maturation. Exp Cell Res 1972; 75: 159–169.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.